Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion
Open Access
- 15 June 1989
- Vol. 63 (12), 2551-2561
- https://doi.org/10.1002/1097-0142(19890615)63:12<2551::aid-cncr2820631233>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- 15 Years Experience with Hyperthermic Perfusion for Treatment of Soft Tissue Sarcoma and Malignant Melanoma of the ExtremitiesPublished by S. Karger AG ,1983
- Prognostic parameters in recurrent malignant melanomaCancer, 1983
- A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous MelanomaNew England Journal of Medicine, 1982
- Hyperthermia and CancerPublished by Springer Nature ,1982
- Surgical adjuvant therapy of malignant melanoma withCorynebacterium parvumCancer, 1981
- Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbsEuropean Journal of Cancer (1965), 1981
- A Multifactorial Analysis of MelanomaAnnals of Surgery, 1981
- Effects of hyperthermia on normal and tumor microenvironment.Radiology, 1980
- RANDOMIZED TRIAL OF BACILLUS CALMETTE‐GUÉRIN (PERCUTANEOUS ADMINISTRATION) AS SURGICAL ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH STAGE‐II MELANOMAAnnals of the New York Academy of Sciences, 1976
- Melanoma of the extremities: Experiences with conventional treatment and perfusion in 339 casesThe American Journal of Surgery, 1965